Spirulina and cancer cachexia.

Cancer cachexia biology

Cachexia affects 50–80% of cancer patients and is directly responsible for 20% of cancer deaths (respiratory failure from diaphragm wasting, cardiac failure). It is not a late-stage phenomenon — it can begin years before diagnosis in some cancers.

• Cytokine-driven catabolism:Tumour cells and host immune cells produce IL-6, TNF-α, and IL-1β that activate NF-κB in skeletal muscle. NF-κB promotes atrogin-1 and MuRF1 (muscle RING finger 1) E3 ubiquitin ligases, targeting myosin heavy chain and other structural proteins for proteasomal degradation.
• Activin A / myostatin:Tumour-derived and tumour-environment-derived activin A activates ActRIIB signalling in muscle, suppressing Akt/mTOR protein synthesis pathways. mTOR is the master regulator of muscle protein synthesis — its suppression prevents muscle rebuilding even with adequate protein intake.
• Energy metabolism disruption:Elevated futile cycling (lipid mobilisation and re-esterification), impaired insulin signalling, and mitochondrial uncoupling increase resting energy expenditure. Eating more does not fully reverse cachexia — the metabolic derangement must be addressed.
• Anorexia component:IL-6 and TNF-α cross the blood-brain barrier and act on hypothalamic appetite centres, suppressing appetite via leptin-independent and ghrelin-independent mechanisms.

Phycocyanobilin and the NF-κB/cachexia axis

• Phycocyanobilin inhibits NF-κB in skeletal muscle — directly targeting the transcription factor that upregulates atrogin-1 and MuRF1. In animal cachexia models, phycocyanin administration reduced atrogin-1 expression, preserved muscle mass, and reduced IL-6 levels.
• NOX2 inhibition reduces ROS in cachectic muscle — oxidative stress in muscle fibres independently activates proteolytic pathways and impairs mitochondrial function required for muscle energy metabolism.
• Reduced systemic IL-6 from NF-κB suppression may also partially restore appetite signalling in the hypothalamus — a secondary mechanism.
• No clinical RCT in cancer cachexia with spirulina or phycocyanin exists. The mechanistic case is directly aligned with cachexia biology; translation to human clinical benefit has not been demonstrated.

Nutritional density in cachexia

Practical nutrition in cachexia is genuinely difficult:

• Anorexia limits intake; nausea from chemotherapy and early satiety from tumour mass further restrict it
• Spirulina at 10 g provides 6 g protein, 360 kJ (85 kcal), and concentrated micronutrients in a volume of approximately 1 tablespoon — one of the highest nutrient density formats available
• Iron deficiency is common in cancer from chronic blood loss, inflammation (anaemia of chronic disease), and treatment toxicity. Spirulina food-matrix iron is relevant — but check ferritin first, as some cancers cause iron accumulation rather than deficiency

Curative vs palliative context

• Curative intent (chemotherapy/radiotherapy/immunotherapy):NK cell stimulation by spirulina is generally viewed as supportive in solid tumours — NK cells contribute to tumour surveillance. Some oncologists allow spirulina; others prefer a cautious approach during active treatment. Always discuss with the oncologist managing treatment.
• Immunotherapy (checkpoint inhibitors: pembrolizumab, nivolumab):These drugs release the immune brakes, enabling T cell and NK cell tumour killing. NK stimulation from spirulina is theoretically complementary. Some oncologists are supportive; others recommend avoiding immunomodulatory supplements to prevent unpredictable interactions. This is an active area of oncology practice variation — confirm with treating team.
• Palliative intent:Nutritional and anti-inflammatory support to maintain quality of life and muscle mass is appropriate. NK stimulation concerns are lower priority in palliative context. Symptom management and patient preference take precedence.

Practical guidance

• Always inform oncologist and oncology dietitian — cancer cachexia management is increasingly multimodal; spirulina fits within the nutritional support component
• Focus on phycocyanin-preserving formats (cold smoothies, cold drinks) for maximum anti-inflammatory and anti-cachectic mechanism
• Start with 3 g/day and increase to 5–10 g as tolerated; nausea from treatment may limit intake
• High-calorie smoothie vehicle: blend with avocado, nut butter, banana, and oat milk to maximise caloric density per serving
• Check ferritin before adding iron from spirulina — many cancers elevate ferritin; verify iron status with oncology team